From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart Failure
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life
Prdm16 Deficiency Leads to Age-Dependent Cardiac Hypertrophy, Adverse Remodeling, Mitochondrial Dysfunction, and Heart Failure
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF Registries
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction